You are here

Front > Search FHI 360

Search FHI 360

Start a New Search

Search within these results

ResearchHealth researchMonitoring and evaluation

5 Results Found

  • Feature

    Adaptive management improves and enables effective social and behavior change programming

    FHI 360 uses an adaptive management approach to improve integrated social and behavior change programming in Tanzania through the USAID Tulonge Afya project.
  • Video

    Assessing the Health Status of Rohingya Refugees in Bangladesh

    FHI 360 Research Director Taufique Joarder joins Research Roundtable to discuss a record review on the health status and needs of Rohingya refugees living in Bangladesh.
  • Published research

    Outcomes of compulsory detention compared to community-based voluntary methadone maintenance treatment in Vietnam

    This research finds conclusive evidence that methadone maintenance treatment (MMT) is more costeffective than center-based compulsory treatment (CCT) in reducing heroin use, blood-borne virus risk behaviors, drug-related illegal behaviors and monthly drug spending. The authors recommend that policymakers consider allocation of resources for MMT treatment a higher priority and scale down CCT models.
  • Published research

    Higher sequence diversity in the vaginal tract than in blood at early HIV-1 infection

    This analysis of early mucosal infections in women revealed high HIV-1 viral diversity in the vaginal tract but few transmitted clones in the blood. This provides novel in vivo evidence for a mucosal sieve effect, leading to the establishment of a homogenous systemic infection. The data will have significant implications in rational vaccine design.
  • Published research

    Safety and tolerability of maraviroc-containing regimens to prevent HIV infection in women: A phase 2 randomized trial

    This study shows that, for U.S. women at risk of HIV infection, pre-exposure prophylaxis (PrEP) regimens containing maraviroc are safe and well-tolerated, compared with the standard regimen of tenofovir disoproxil fumarate/emtricitabine. The authors also found that no new infections occurred with the study regimen, compared with the standard regimen, but more research is needed to determine whether that outcome is because of the study drug and whether the enrolled population was lower risk than anticipated.